NICE launches refreshed support service for life sciences industry

6 November 2023 - NICE has today launched its refreshed support service for the life sciences sector, NICE Advice.  ...

Read more →

High drug prices are not justified by industry’s spending on research and development

15 February 2023 - Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative ...

Read more →

Integrating early economic evaluation into target product profile development for medical tests: advantages and potential applications

7 June 2021 - Target product profiles outline the characteristics that new health care technologies require to address an unmet clinical ...

Read more →

Labour peer says he opposes Corbyn-style state-funded drugs firm

12 November 2019 - A Labour peer has spoken out against the idea of a nationalised drugs industry, saying that ...

Read more →

Subscription model for antibiotic development

6 September 2019 - An unlikely answer to the global crisis in antibiotic resistance. ...

Read more →

Take over pharma to create new medicines, says top adviser

27 March 2019 - Part of the drugs industry should be taken over to make new antibiotics, an influential economist ...

Read more →

Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model in a pharmaceutical company

21 February 2019 - Evidence requirements and assessment methods access differ between health technology assessment agencies.  ...

Read more →

NICE Scientific Advice launches collaborative programme with life sciences industry body

29 January 2019 - NICE has announced a collaboration with the body which represents life sciences organisations in the UK. ...

Read more →

Building synergy between regulatory and HTA agencies beyond processes and procedures—can we effectively align the evidentiary requirements? A survey of stakeholder perceptions

13 June 2018 - The pathway for bringing a new medicine to the market is dependent on two sequential processes: achieving ...

Read more →

Taxpayer-funded drugs 'too expensive for patients’

22 October 2017 - Taxpayer-funded medical research is producing medicines which are increasingly unaffordable for patients who need them, says ...

Read more →

NICE launches a competition for developers of health care technologies

27 June 2017 - NICE Scientific Advice has launched a competition for small or medium sized companies, charities and academic research ...

Read more →

NICE to launch new evidence tool for medtech product developers

30 May 2017 - NICE is launching an online tool to help medtech companies get their products to patients faster. ...

Read more →